Have some news you want to share with the Oregon Bio community? Fill out our submission form.
The DHS guidelines on essential critical infrastructure updated to include lab personnel working outside COVID-19
In previous publications, the CISA guidance was limited to, “Workers conducting research critical to COVID-19 response”. The new version also includes “Workers, including lab personnel who perform critical biomedical research, development, and testing, needed for COVID-19 response or other diseases”. For complete details we have provided the publication:
Taking too long?
Open in new tab
Oregon Bio has partnered with other major trade organizations serving Oregon and Washington to develop a resource/supply/inventory exchange. One of our partners, Pacific Northwest Defense Coalition (PNDC), shares this perspective gleaned from contact with the Department of Homeland Security (DHS) procurement teams, on how local companies can sell to FEMA for the COVID-19 response.
By Jonathan Bach – Staff Reporter, Portland Business Journal
Oregon has unveiled a tool to help get small businesses connected with financial resources and information to stay afloat during the coronavirus pandemic.
Governor Kate Brown announced the tool, called the Coronavirus Small Business Resource Navigator, on Thursday.
Global plasma leaders collaborate to accelerate development of potential COVID-19 hyperimmune therapy
Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19
Osaka, JAPAN, and King of Prussia, PA, USA – April 6, 2020 – Biotest, BPL Group, LFB, and Octapharma have joined an alliance formed by CSL Behring (ASX:CSL/USOTC:CSLLY) and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) to develop a potential plasma-derived therapy for treating COVID-19. The alliance will begin immediately with the investigational development of one, unbranded anti-SARS-CoV-2 polyclonal hyperimmune immunoglobulin […]
When the news of the coronavirus first emerged, Gilead immediately began to consider the potential of remdesivir, an investigational antiviral in development. The responsibility is to ensure that remdesivir is effective and safe before it is distributed for use worldwide. Multiple clinical trials are ongoing.
ASTM International, formerly known as American Society for Testing and Materials, is an international standards organization that develops and publishes voluntary consensus technical standards for a wide range of materials, products, systems, and services.
NemaMetrix expands business to capitalize on In-vivo solutions to help speed testing for critical disease therapeutics
Company Changes Operating Name to InVivo Biosystems
Eugene, Ore. – March 31, 2020 – NemaMetrix is changing its operating name to InVivo Biosystems as the company expands its research platforms to accelerate deep in-vivo insights that help researchers develop and deliver therapeutic solutions for critical diseases. The company’s solutions now provide essential services to pharmaceutical, nutraceuticals, and biotechnology companies around the world to speed research and drug development efforts, enabling earlier insights by closing the gap between cells and mice. The company’s new capabilities help […]
Oregon Bio, as a service to members during this time of COVID-19, is developing a list of experts in subject matter and resources who have local expertise in inventory, supply, research and potential availability of resources including PPE, research capabilities and needed infrastructure, supplies/inventories, testing kit components, and care treatment and protocols. Please send your information, contact details and description of your expertise to email@example.com.